Applied DNA Sciences's EPS (Basic) for the
three
months ended in Jun. 2024 was $0.47.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $-11.99.
During the past 3 years, the average EPS without NRIGrowth Rate was 37.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 44.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 32.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Applied DNA Sciences's highest 3-Year average EPS without NRI Growth Rate was 68.80% per year. The lowest was -1056.70% per year. And the median was 18.40% per year.
Applied DNA Sciences EPS (Diluted) Historical Data
The historical data trend for Applied DNA Sciences's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Applied DNA Sciences's EPS (Diluted)
For the Diagnostics & Research subindustry, Applied DNA Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied DNA Sciences's PE Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's PE Ratio distribution charts can be found below:
* The bar in red indicates where Applied DNA Sciences's PE Ratio falls into.
Applied DNA Sciences EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Applied DNA Sciences's Diluted EPS for the fiscal year that ended in Sep. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences (NAS:APDN) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Applied DNA Sciences EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Applied DNA Sciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APDN has been successfully added to your 